Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older

Lung Cancer. 2003 Aug;41(2):233-4. doi: 10.1016/s0169-5002(03)00199-5.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Cisplatin / administration & dosage*
  • Cisplatin / adverse effects
  • Drug Administration Schedule
  • Etoposide / administration & dosage*
  • Etoposide / adverse effects
  • Feasibility Studies
  • Female
  • Health Services for the Aged
  • Humans
  • Infusions, Intravenous
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Treatment Outcome

Substances

  • Etoposide
  • Cisplatin